Thrombotic arterial complications in patients hospitalized for COVID-19 in a regional hospital in Paraguay
Article Sidebar
Main Article Content
Abstract
Introduction: although respiratory failure remains the hallmark and leading cause of death from moderate to severe COVID-19, several cardiovascular complications and numerous cases of thromboembolic disease have been reported.
Objectives: to determine the prevalence of thrombotic arterial complications in patients hospitalized for COVID-19 in a regional hospital in Paraguay during 2020.
Methodology: the study was quantitative, observational and descriptive with an analytical component that included patients with a diagnosis of COVID-19 confirmed by PCR or IgM-IgG serology who were admitted to the Regional Hospital, selected through non-probabilistic convenience sampling.
Results: of 282 clinical records, 71% corresponded to males with a median age of 60 years (P25=31 P75=65). 88% of the patients presented a thrombotic arterial complication, where the most altered laboratory value was CRP in 95%. The association between the variables of comorbidity (Peripheral Arterial Disease, COPD, Coronary Heart Disease, Stroke) and prevalence of thrombotic arteries and thus also the D-Dimer (17671,01±22356,21), yielded a statistically significant result.
Conclusions: the high rate of thrombotic arterial complications in patients with COVID-19 is alarming, in addition to the association of D-Dimer and comorbidities with arterial complications marks the north of the future of their prognosis.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Velázquez- Pérez L. La COVID-19 : reto para la ciencia mundial. Anales de la Academia de Ciencias de Cuba [Internet]. 2020;10(2):2-3. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/763/792.
Paraguay. Ministerio de Salud Pública y Bienestar Social. Reportes- COVID [Internet]. Asunción: El Ministerio.2021. Disponible en: https://www.mspbs.gov.py/reporte-covid19.html
Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Sig Transduct Target Ther [Internet]. 2020;128:1-8. Disponible en: https://www.nature.com/articles/s41392-020-00243-2
Becker RC. Covid 19 uptodate: associated coagulopathy. J Thromb Thrombolysis [Internet]. 2020;50(1):54-67. Disponible en: https://doi.org/10.1007/s11239-020-02134-3
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7.
Rey JR, Cordón JC, Pineda D, Merino J, Iniesta Á, López- Sendón J. Complicaciones arteriales tromboticas en pacientes hospitalizados con COVID-19. Rev Española Cardiol [Internet]. 2020;73(9):769-82. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0300893220302839?via%3Dihub
López- Reyes R, Oscullo G, Jiménez D, Cano I, García- Ortega A. Riesgo trombótico y COVID-19: revisión de la evidencia actual para una mejor aproximación diagnóstica y terapéutica. Elsevier [Internet]. 2021;57(suppl 1):55-64. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0300289620302684
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-6. doi:10.1001/jama.2020.4683
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16): 1574-81. doi: 10.1001/jama.2020.5394.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID‐19 - Terpos - 2020 - American Journal of Hematolog. AMJ- Hematol [Internet]. 2020;95:834-47. Disponible en: https://onlinelibrary.wiley.com/journal/10968652
Montiel D, Torres E, Acosta A, Sobarzo P, Pérez H, Ávalos D, et al. Vista de Características clínicas, laboratoriales y predictores de mortalidad de pacientes con COVID-19 internados en el Hospital Nacional.pdf. Rev Científica Ciencias la Salud [Internet]. 2021;3(1):26-37. Disponible en: http://www.upacifico.edu.py:8040/index.php/PublicacionesUP_Salud/article/view/132/193
Trujillo-Araujo AK, Cossío-Zazueta A, Camarillo-Nava VM, Serrato-Auld RC. Trombosis aguda arterial y venosa en pacientes infectados con COVID-19. Rev Mex Angiol [Internet]. 2021;49(2):45-50. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2696-130X2021000200045
Becker RC. Covid 19 associated coagulopathy. J Thromb Thrombolysis [Internet]. 2020;50(1):54-67. Disponible en: https://doi.org/10.1007/s11239-020-02134-3
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7.
Abreu Pérez MR, Tejeda Gómez JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev Habanera Ciencias Médicas [Internet]. 2020;19(2):1-15. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505
Saldías Peñafiel F, Peñaloza Tapia A, Farías Nesvadba D, Farcas Oksenberg K, Reyes Sánchez A, Cortés Meza J, et al. Manifestaciones clínicas y predictores de gravedad en pacientes adultos con infección respiratoria aguda por coronavirus SARS-CoV-2. Rev Med Chil [Internet]. 2020;148(10):1387-97. Disponible en: https://scielo.conicyt.cl/pdf/rmc/v148n10/0717-6163-rmc-148-10-1387.pdf
Organización Panamericana de la Salud (OPS). Informes de situación de la Covid-19. Disponible en: https://www.paho.org/es/informes-situacion-covid-19
Recalde MK. Correlación entre las coagulopatias y la infección por COVID-19 [Internet]. Universidad de Guayaquil; 2020. Disponible en: http://repositorio.ug.edu.ec/handle/redug/51521
Santos RP, Martins LG, Tomich de M, Oliveira Fraga MC, Scarpellin F, De Miranda Godoy CS, et al. Coinfección por Leishmaniasis y Paracoccidioidomicosis y complicaciones trombóticas graves por Covid-19. Elsevier [Internet]. 2021;25:7-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936792/pdf/main.pdf
Marlem L, Travieso C, Tania ID, Carballo I, Maiyurik D, León G, et al. Marcadores de trombosis en pacientes con trombofilia Markers of thrombosis in patient with thrombophilia. 2014;53(1):14-24.
Sabio R. Compromiso cardiovascular en pacientes afectados por Covid-19. Rev Argentina Med [Internet]. 2020;8(3):200-3. Disponible en: https://revistasam.com.ar/index.php/RAM/article/download/468/388
Esteban F, González J, Fátima G De, Alulima J, Lizeth E, Auquilla S, et al. Hipercoagulabilidad, trombosis intravascular y trombocitosis asociada al COVID-19. Reporte de un caso. Rev Bionatura [Internet]. 2020;5(2):7-10. Disponible en: http://revistabionatura.com/2020.05.02.11.html
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA - J Am Med Assoc. 2020;323(18):1775-6.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Vol. 323, JAMA - Journal of the American Medical Association. 2020. p. 1574-81.